Screener
ClearPoint Neuro CLPT Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by ClearPoint Neuro in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: ClearPoint Neuro’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221890
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net cash flows from operating activities | (7,967) | (6,172) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (645) | (183) |
| Net cash flows from investing activities | (645) | (183) |
| Cash flows from financing activities: | ||
| Payment of At-The-Market offering costs | — | (78) |
| Proceeds from stock option exercises | 148 | 21 |
| Payments for taxes related to net share settlement of equity awards | (1,993) | (1,305) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is ClearPoint Neuro's investing cash flow?
- ClearPoint Neuro (CLPT) reported investing cash flow of -$645K in Q1 2026.
- How has ClearPoint Neuro's investing cash flow changed year-over-year?
- ClearPoint Neuro's investing cash flow decreased by 252.5% year-over-year, from -$183K to -$645K.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about ClearPoint Neuro's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude